<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta http-equiv="Content-Type" content="text/html;charset=utf-8"/>
    <title>HL7.EU.FHIR.GH\910d1748-674b-430c-b4ab-3665b266a31f - TTL Representation - FHIR v4.1.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link rel="stylesheet" href="fhir.css"/>

      <!-- Bootstrap core CSS -->
    <link rel="stylesheet" href="assets/css/bootstrap-fhir.css"/>

      <!-- Project extras -->
    <link rel="stylesheet" href="assets/css/project.css"/>
    <link rel="stylesheet" href="assets/css/pygments-manni.css"/>
    <link rel="stylesheet" href="assets/css/jquery-ui.css"/>
  	<link rel="stylesheet" href="assets/css/prism.css"/>
      <!-- Placeholder for child template CSS declarations -->
    <link rel="stylesheet" href="assets/css/pcsp.css"/>

    <script src="fhir-table-scripts.js" type="text/javascript"> </script>

      <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
      <!-- [if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif] -->

      <!-- Favicons -->
    <link sizes="144x144" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link sizes="114x114" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link sizes="72x72" rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"8.9"}
    h3,h4,h5,h6{--heading-prefix:"8.9"}</style>
    <div id="segment-header" class="segment">    <!-- segment-header -->
      <div class="container">    <!-- container -->
        
        <div id="hl7-nav">
          <a no-external="true" id="hl7-logo" href="https://www.gravitatehealth.eu/">
            <img src="assets/images/logo-header.jpg" alt="Visit the Project website" height="60"/>
          </a>
        </div>
   <!-- <div id="family-nav">
          <a id="family-logo" no-external="true" href="https://www.pancare.eu/projects"><img height="40" alt="Visit the PanCareSurPass website" src="assets/images/who-logo-www.jpg"/> </a>
        </div> -->
        <div id="hl7-search">
          <a no-external="true" id="hl7-search-lnk" href="http://hl7.org/fhir/search.cfm"><img src="assets/images/search.png" alt="Search FHIR"/></a>
        </div>


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">Gravitate Health FHIR Implementation Guide</span><br/>0.1.0 - CI Build</p>
        </div>
      </div>   <!-- /container -->
    </div>    <!-- /segment-header -->

    <div id="segment-navbar" class="segment">    <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">    <!-- container -->
          <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
            <!-- status-bar -->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" data-toggle="collapse" type="button" class="navbar-toggle">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a href="http://build.fhir.org/index.html" class="navbar-brand hidden">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
                <!-- menu.xml -->

<ul class="nav navbar-nav">
  <li>
    <a href="index.html">IG Home</a>
  </li>
  <li>
    <a href="toc.html">Table of Contents</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Capability Statements
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="CapabilityStatement-capability-statement-ema.html">SmPC / PL</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="artifacts.html">Artifact Index</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Support
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="http://hl7.org/fhir/R4/index.html">FHIR Spec</a>
      </li>
      <li>
        <a href="downloads.html">Downloads</a>
      </li>
    </ul>
  </li>
</ul>
            </div>    <!-- /.nav-collapse -->
          </div>    <!-- /.container -->
        </nav>    <!-- /.navbar -->
        <!-- /HEADER CONTENT -->
      </div>    <!-- /container -->
    </div>    <!-- /segment-navbar -->
      <!-- status-bar -->

    <div id="segment-breadcrumb" class="segment">    <!-- segment-breadcrumb -->
      <div class="container">    <!-- container -->
        <ul class="breadcrumb">
          <li><a href="toc.html"><b>Table of Contents</b></a></li><li><a href="artifacts.html"><b>Artifacts Summary</b></a></li><li><b>910d1748-674b-430c-b4ab-3665b266a31f</b></li>

        </ul>
      </div>    <!-- /container -->
    </div>    <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">    <!-- segment-content -->
      <div class="container">    <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div style="counter-reset: section 9" class="col-12">
  <!-- ReleaseHeader --><p id="publish-box">Gravitate Health FHIR Implementation Guide - Local Development build (v0.1.0). See the <a href="http://hl7.eu/fhir/ig/gravitate-health/history.html">Directory of published versions</a></p>  <!-- EndReleaseHeader -->







<ul class="nav nav-tabs">

  <li>
    <a href="Bundle-910d1748-674b-430c-b4ab-3665b266a31f.html">Narrative Content</a>
  </li>


  
    <li>
      <a href="Bundle-910d1748-674b-430c-b4ab-3665b266a31f.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="Bundle-910d1748-674b-430c-b4ab-3665b266a31f.json.html">JSON</a>
    </li>
  


  
    <li class="active">
      <a href="#">TTL</a>
    </li>
  



</ul>


<a name="root"> </a>


<h2 id="root">: 910d1748-674b-430c-b4ab-3665b266a31f - TTL Representation</h2>

<p><a href="Bundle-910d1748-674b-430c-b4ab-3665b266a31f.ttl" no-download="true">Raw ttl</a> | <a download="null" href="Bundle-910d1748-674b-430c-b4ab-3665b266a31f.ttl">Download</a></p>

    <!-- insert intro if present -->
  



  <pre class="rdf"><code class="language-turtle"><a name="2b33956e-199c-4fc2-acd3-3a86c5c5571c">​</a>
@prefix fhir: &lt;http://hl7.org/fhir/&gt; .
@prefix owl: &lt;http://www.w3.org/2002/07/owl#&gt; .
@prefix rdfs: &lt;http://www.w3.org/2000/01/rdf-schema#&gt; .
@prefix xsd: &lt;http://www.w3.org/2001/XMLSchema#&gt; .

# - resource -------------------------------------------------------------------

 a fhir:Bundle;
  <a href="http://build.fhir.org/rdf.html#tree-root">fhir:nodeRole</a> fhir:treeRoot;
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.id">fhir:Resource.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "910d1748-674b-430c-b4ab-3665b266a31f"];
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.meta">fhir:Resource.meta</a> [
     <a href="http://build.fhir.org/branches/R4B//resource.html#Meta#Meta.versionId">fhir:Meta.versionId</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "1" ];
     <a href="http://build.fhir.org/branches/R4B//resource.html#Meta#Meta.lastUpdated">fhir:Meta.lastUpdated</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#instant">fhir:value</a> "2021-06-25T20:28:04.643+00:00"^^xsd:dateTime ]
  ];
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.identifier">fhir:Bundle.identifier</a> [
     <a href="http://build.fhir.org/branches/R4B//datatypes.html#Identifier#Identifier.system">fhir:Identifier.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://ema.europa.eu/fhir/identifier/documentid" ];
     <a href="http://build.fhir.org/branches/R4B//datatypes.html#Identifier#Identifier.value">fhir:Identifier.value</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "d6492916-2a98-4ea8-a938-324d5e5c471b" ]
  ];
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.type">fhir:Bundle.type</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "document"];
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.timestamp">fhir:Bundle.timestamp</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#instant">fhir:value</a> "2021-06-25T20:28:01+00:00"^^xsd:dateTime];
  <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.entry">fhir:Bundle.entry</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//bundle.html#Bundle.entry.fullUrl">fhir:Bundle.entry.fullUrl</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "urn:uuid:f51d10d6-a536-4039-a9c2-9459339cf52e" ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition">fhir:Bundle.entry.resource</a> &lt;urn:uuid:f51d10d6-a536-4039-a9c2-9459339cf52e&gt;
  ].

&lt;urn:uuid:f51d10d6-a536-4039-a9c2-9459339cf52e&gt; <a href="http://build.fhir.org/branches/R4B//composition.html">a</a> fhir:Composition;
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.language">fhir:Resource.language</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "en"];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.text">fhir:DomainResource.text</a> [
     <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "generated" ];
     fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"&gt;&lt;p&gt;&lt;b&gt;Generated Narrative&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;status&lt;/b&gt;: final&lt;/p&gt;&lt;p&gt;&lt;b&gt;type&lt;/b&gt;: &lt;span title=\"Codes: {http://spor.ema.europa.eu/v1/lists/100000155531 100000155532}\"&gt;SUMMARY OF PRODUCT CHARACTERISTICS&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;date&lt;/b&gt;: 2021-02-01&lt;/p&gt;&lt;p&gt;&lt;b&gt;author&lt;/b&gt;: &lt;span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;title&lt;/b&gt;: Acme Product&lt;/p&gt;&lt;h3&gt;RelatesTos&lt;/h3&gt;&lt;table class=\"grid\"&gt;&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;&lt;b&gt;Code&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Target[x]&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;*&lt;/td&gt;&lt;td&gt;appends&lt;/td&gt;&lt;td&gt;&lt;a href=\"${document[n].relatesTo}\"&gt;${document[n].relatesTo}&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;"
  ];
  <a href="http://build.fhir.org/branches/R4B//binary.html#Binary">fhir:DomainResource.contained</a> [
     <a href="http://build.fhir.org/branches/R4B//binary.html">a</a> fhir:Binary;
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//binary.html#Binary.id">fhir:Resource.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "stylesheet0" ];
     <a href="http://build.fhir.org/branches/R4B//binary.html#Binary.contentType">fhir:Binary.contentType</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "stylesheet/css" ];
     <a href="http://build.fhir.org/branches/R4B//binary.html#Binary.data">fhir:Binary.data</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#base64Binary">fhir:value</a> "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"^^xsd:base64Binary ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.extension">fhir:DomainResource.extension</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//extensibility.html#Extension#Extension.url">fhir:Extension.url</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://ema.europa.eu/fhir/extension/dummyValidationReference" ];
     <a href="http://build.fhir.org/branches/R4B//extensibility.html#Extension#Extension.value[x]">fhir:Extension.valueReference</a> [
       <a href="http://build.fhir.org/branches/R4B//references.html#Reference#Reference.reference">fhir:Reference.reference</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "#stylesheet0" ]     ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.status">fhir:Composition.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "final"];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.type">fhir:Composition.type</a> [
     <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
       <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/lists/100000155531" ];
       <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "100000155532" ];
       <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "SUMMARY OF PRODUCT CHARACTERISTICS" ]     ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.subject">fhir:Composition.subject</a> [
     <a href="http://build.fhir.org/branches/R4B//references.html#Reference#Reference.reference">fhir:Reference.reference</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "[]" ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.date">fhir:Composition.date</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#dateTime">fhir:value</a> "2021-02-01"^^xsd:date];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.author">fhir:Composition.author</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//references.html#Reference#Reference.identifier">fhir:Reference.identifier</a> [
       <a href="http://build.fhir.org/branches/R4B//datatypes.html#Identifier#Identifier.system">fhir:Identifier.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "[]" ]     ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.title">fhir:Composition.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Acme Product"];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.relatesTo">fhir:Composition.relatesTo</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.relatesTo.code">fhir:Composition.relatesTo.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "appends" ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.relatesTo.target[x]">fhir:Composition.relatesTo.targetReference</a> [
       <a href="http://build.fhir.org/branches/R4B//references.html#Reference#Reference.reference">fhir:Reference.reference</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "${document[n].relatesTo}" ]     ]
  ];
  <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section">fhir:Composition.section</a> [
     <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "fe90a14e-4030-46e8-865e-2f2605b26c4c" ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "SUMMARY OF PRODUCT CHARACTERISTICS" ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
       <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "1" ];
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "SUMMARY OF PRODUCT CHARACTERISTICS" ]       ]     ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
       <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
       fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                            &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,serif;  color:green\" lang=\"EN-GB\"&gt;\n                                &lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;\n                            &lt;/span&gt;\n                            &lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;\n                        &lt;/div&gt;"     ];
     <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "307ef8dd-16df-48e5-86de-2f6c967d0025" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "1.       NAME OF THE MEDICINAL PRODUCT" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "3" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "1. NAME OF THE MEDICINAL PRODUCT" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg gastro‑resistant tablets&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;gastro‑resistant tablets&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "1fe066ba-bb1a-446c-ab2f-6ed62f66b371" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "2.       QUALITATIVE AND QUANTITATIVE COMPOSITION" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "4" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "2. QUALITATIVE AND QUANTITATIVE COMPOSITION" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;u&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                    &lt;/u&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Each &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;gastro‑resistant tablet&lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;contains 30 mg dimethyl fumarate.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;u&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                    &lt;/u&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Each &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;gastro‑resistant tablet&lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;contains 120 mg dimethyl fumarate.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "12ef092e-11a7-4a2b-bb69-16beea26c8b9" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Excipient with known effect" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "7" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Excipient(s) with known effect" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Each &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;gastro‑resistant tablet&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;contains 34.2 mg lactose (as &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;monohydrate)&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Each &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;gastro‑resistant tablet&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;contains 136.8 mg lactose (as monohydrate).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;For the full list of excipients, see section 6.1.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "248e1319-4e22-4c97-bee3-8ba8fa5eca0b" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "3.       PHARMACEUTICAL FORM" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "8" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "3. PHARMACEUTICAL FORM" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Gastro‑resistant tablet.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;u&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                    &lt;/u&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;White, film-coated, round, biconvex &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;tablet&lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;with a diameter of approximately 6.8 mm.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;u&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                    &lt;/u&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Blue, film-coated, round, biconvex &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;tablet with a diameter of approximately 11.6 mm.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "edee7185-44da-41cb-9143-a1c0753cfecf" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.       CLINICAL PARTICULARS" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "9" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4. CLINICAL PARTICULARS" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "629e8aa5-3958-4910-8794-dc506c61331a" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.1     Therapeutic indications" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "10" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.1 Therapeutic indications" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product is indicated for the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "ac695909-94e0-4904-b112-314b67beac99" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.2     Posology and method of administration" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "11" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.2 Posology and method of administration" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of psoriasis.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                &lt;/div&gt;"         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "3cd4f0da-98e4-4648-ac69-2331e2e6fc08" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Posology" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "12" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Posology" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;To improve tolerability, it is recommended to begin treatment with a low initial dose with subsequent gradual increases. In the first week, Acme Product 30 mg is taken once daily (1 tablet in the evening). In the second week, Acme Product 30 mg is taken twice daily (1 tablet in the morning and 1 in the evening). In the third week, Acme Product 30 mg is taken three times daily (1 tablet in the morning, 1 at midday, and 1 in the evening). From the fourth week, treatment is switched to only 1 tablet of Acme Product 120 mg in the evening. This dose is then increased by 1 Acme Product 120 mg tablet per week at different times of day for the subsequent 5 weeks, as shown in the table below. The maximum daily dose allowed is 720 mg (3 x 2 tablets of Acme Product 120 mg).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\" style=\"width:100.0%;border-collapse:collapse\" class=\"Tablanormal\"&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border:solid windowtext 1.0pt;    border-bottom:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Week&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"62%\" style=\"width:62.5%;border:solid windowtext 1.0pt;    border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Number of tablets&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:solid windowtext 1.0pt;    border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Total daily dose (mg)&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Morning&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:solid windowtext 1.0pt;    border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Midday&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:solid windowtext 1.0pt;    border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Evening&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;of dimethyl fumarate &lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"4\" width=\"72%\" style=\"width:72.92%;border-top:none;    border-left:solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;    border-right:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;30&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;60&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border:solid windowtext 1.0pt;border-top:    none;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;3&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;90&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"4\" width=\"72%\" style=\"width:72.92%;border-top:none;border-left:    solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:    none;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:11.55pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt;    height:11.55pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;4&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:11.55pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:11.55pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:11.55pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:11.55pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;120&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:12.65pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt;    height:12.65pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;5&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.65pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.65pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;0&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.65pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.65pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;240&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:16.15pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt;    height:16.15pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;6&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:16.15pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:16.15pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:16.15pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:16.15pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;360&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:12.1pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt;    height:12.1pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;7&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.1pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.1pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.1pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:12.1pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;480&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:13.25pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border-top:none;border-left:solid windowtext 1.0pt;    border-bottom:none;border-right:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt;    height:13.25pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;8&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:13.25pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:13.25pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;1&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:13.25pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border:none;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:13.25pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;600&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr style=\"height:15.85pt\"&gt;\n                                                &lt;td width=\"10%\" style=\"width:10.42%;border:solid windowtext 1.0pt;border-top:    none;padding:1.4pt 5.4pt 1.4pt 5.4pt;height:15.85pt\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;9+&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:15.85pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:15.85pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"20%\" style=\"width:20.84%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:15.85pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;2&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"27%\" style=\"width:27.08%;border-top:none;border-left:none;    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt;height:15.85pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span lang=\"EN-GB\"&gt;720&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                        &lt;/table&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;If a particular dose increase is not tolerated, it may&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;be temporarily reduced to the last tolerated dose.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;If treatment success is observed before the maximum dose is reached, no further increase of dose is necessary. After clinically relevant improvement of the skin lesions has been achieved, consideration should be given to gradual reduction of the daily dose of Acme Product to the maintenance dose required by the individual.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Dosage modifications may also be necessary if&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;abnormalities in laboratory parameters are observed &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;(see section 4.4).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;i&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;Elderly patients&lt;/span&gt;\n                                            &lt;/i&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Clinical studies of Acme Product did not include sufficient numbers of patients aged 65 years and above to determine whether they respond differently compared to patients under 65 years (see section 5.2). Based on the pharmacology of dimethyl fumarate, a need for dose adjustment in the elderly is not expected.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;i&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;\n                                            &lt;/i&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;No dose adjustment is needed in patients &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;with mild to moderate renal impairment (see section 5.2).&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product has not been studied in patients with severe renal impairment, and use of Acme Product is contraindicated in these patients (see section 4.3).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;i&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;\n                                            &lt;/i&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;No dose adjustment is needed in patients &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;with mild to moderate hepatic impairment (see section 5.2).&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product has not been studied in patients with severe hepatic impairment, and use of Acme Product is contraindicated in these patients (see section 4.3).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "f3544eb5-1cdd-4a65-a815-2c9119be0504" ];
             <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Paediatric population" ];
             <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
                 <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
                 <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
                 <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "13" ];
                 <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Paediatric population" ]               ]             ];
             <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
               <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
               fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                            &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;The safety and efficacy of Acme Product in paediatric population below the age of 18 years have not been established. There are no data available with Acme Product in paediatric population.&lt;/span&gt;\n                                            &lt;/p&gt;\n                                            &lt;p style=\"line-height:normal;text-autospace:none\" class=\"MsoNormal\"/&gt;\n                                        &lt;/div&gt;"             ]           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "9604c7e5-77de-4c81-8b69-2c6eb88de9be" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Method of administration" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "14" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Method of administration" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product is for oral use.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product tablets must be swallowed whole with fluid during or immediately after a meal.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The coating of the gastro‑resistant tablets is designed to prevent gastric irritation. Therefore, the tablets should not be crushed, divided, dissolved or chewed.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "2bf255a3-aab0-48cf-aa70-41bc28641ae0" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.3     Contraindications" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "16" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.3 Contraindications" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"margin-top:0in;margin-right:0in;margin-bottom:  0in;margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\" class=\"Prrafodelista\"&gt;\n                                        &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,sans-serif\" lang=\"EN-GB\"&gt;‒&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"margin-top:0in;margin-right:0in;margin-bottom:  0in;margin-left:28.35pt;text-indent:-28.35pt\" class=\"Prrafodelista\"&gt;\n                                        &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,sans-serif\" lang=\"EN-GB\"&gt;‒&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;Severe gastrointestinal disorders.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"margin-top:0in;margin-right:0in;margin-bottom:  0in;margin-left:28.35pt;text-indent:-28.35pt\" class=\"Prrafodelista\"&gt;\n                                        &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,sans-serif\" lang=\"EN-GB\"&gt;‒&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;Severe hepatic or renal impairment.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"margin-top:0in;margin-right:0in;  margin-bottom:0in;margin-left:28.35pt;text-indent:-28.35pt\" class=\"PrrafodelistaCxSpLast\"&gt;\n                                        &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;,sans-serif\" lang=\"EN-GB\"&gt;‒&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;Pregnancy and breast-feeding.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "52fbef30-5b80-4ece-8b05-772b36916b89" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.4     Special warnings and precautions for use" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "17" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.4 Special warnings and precautions for use" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Haematology&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product may decrease leukocyte and lymphocyte counts (see section 4.8). It has not been studied in patients with pre-existing low leukocyte or lymphocyte counts.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Before treatment&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Prior to initiating treatment with &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product, a current complete blood count (including differential blood count and platelet count) should be available. Treatment should not be initiated if&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;leukopenia&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;below 3.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L,\n                                        &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;lymphopenia below &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;1.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L\n                                        &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;or other pathological results are identified.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;During treatment&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;During treatment a complete blood count with differential should be performed every 3 months. Action is needed in the following circumstances:&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" id=\"3de69782-1a9a-4ad4-895d-e8578e4f0ffa\" class=\"MsoNormal\"/&gt;\n                                    &lt;i&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Leukopenia:&lt;/span&gt;\n                                    &lt;/i&gt;\n                                    &lt;none/&gt;\n                                    &lt;p style=\"line-height:normal\" id=\"3de69782-1a9a-4ad4-895d-e8578e4f0ffa\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;If a marked decrease in the total number of white blood cells isfound, the situation should be monitored carefully and treatment withAcme Product should be discontinued at levels below 3.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" id=\"ca0bf9c4-c58f-40b6-8adc-462ad91e700d\" class=\"MsoNormal\"/&gt;\n                                    &lt;i&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Lymphopenia:&lt;/span&gt;\n                                    &lt;/i&gt;\n                                    &lt;none/&gt;\n                                    &lt;p style=\"line-height:normal\" id=\"ca0bf9c4-c58f-40b6-8adc-462ad91e700d\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;If the lymphocyte count falls below 1.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L\n                                        &lt;/span&gt;\n                                        &lt;span style=\"color:black\" lang=\"EN-GB\"&gt;but is ≥0.7 x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L\n                                        &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;, blood monitoring should be performed monthly until levels returnto 1.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L or higher for two consecutive blood tests at whichpoint monitoring can again be performed every 3&nbsp;months.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;If the\nlymphocyte count falls below 0.7x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L, the blood test must be\nrepeated and if the levels are confirmed to be below 0.7x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L, then\ntreatment must be stopped immediately. Patients developing lymphopenia should\nbe monitored after stopping treatment until their lymphocyte count has returned\nto the normal range (see section 4.8).\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Other haematological disorders&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Therapy should be discontinued and caution is advised if other pathological results occur. In any case blood counts should be monitored until values have returned to the normal range.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Infections&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product is an immunomodulator and may affect the way the immune system responds to infection. For p&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;atients with pre‑existing infections of clinical relevance, the physician should decide if treatment with Acme Product should only be initiated once the infection has resolved. If a patient develops an infection during treatment with Acme Product, suspension of treatment should be considered and the benefits and risks should be reassessed prior to re-initiation of therapy. Patients receiving Acme Product should be instructed to report symptoms of infection to a physician.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Opportunistic infections/progressive multifocal leukoencephalopathy (PML)&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Cases of opportunistic infections, particularly of progressive multifocal leukoencephalopathy (PML) have been reported with other dimethyl fumarate-containing products (see section 4.8). PML is an opportunistic infection caused by the John‑Cunningham virus (JCV) that can be fatal or cause severe disabilities. PML is probably caused by a combination of factors.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;A previous infection with JCV is considered a prerequisite for the development of PML. Risk factors can include previous immunosuppressive treatment and the existence of certain concomitant disorders (such as some autoimmune disorders or malignant haematological conditions). A modified or weakened immune system as well as genetic or environmental factors can also constitute risk factors.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Persistent moderate or severe lymphopenia during treatment with dimethyl fumarate is also considered a risk factor for PML. Patients who develop lymphopenia should be monitored for signs and symptoms of opportunistic infections, particularly for symptoms indicative of PML. Typical symptoms associated with PML are diverse, become worse over days to weeks and include progressive weakness on one side of the body or clumsiness of limbs, disturbance of vision and changes in thinking, memory and orientation leading to confusion and personality changes. If PML is suspected, treatment with Acme Product should be stopped immediately and further appropriate neurological and radiological examinations performed.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Prior &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;and concomitant &lt;/span&gt;\n                                        &lt;/u&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;treatment with immunosuppressive or immunomodulating therapies&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Limited&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;data are available on the efficacy and safety of Acme Product in patients who have been previously treated with other immunosuppressive or immunomodulating therapies. When switching patients from such therapies to Acme Product, the half-life and mode of action of the other therapy should be considered in order to avoid additive effects on the immune system.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No data are available on the efficacy and safety of Acme Product when taken concomitantly with other immunosuppressive or immunomodulating therapies (see section 4.5).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Pre‑existing gastrointestinal disease&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"page-break-after:avoid;text-autospace:ideograph-numeric ideograph-other\" class=\"Default\"&gt;\n                                        &lt;span style=\"font-size:11.0pt;color:windowtext\" lang=\"EN-GB\"&gt;Acme Product has not been studied in patients with pre-existing gastrointestinal disease.&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;Acme Product is contraindicated in patients with severe &lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;gastrointestinal disease &lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt;color:windowtext\" lang=\"EN-GB\"&gt;(see sections 4.3)&lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"EN-GB\"&gt;. Gastrointestinal tolerability can be improved by following the &lt;/span&gt;\n                                        &lt;span style=\"font-size:11.0pt;color:windowtext\" lang=\"EN-GB\"&gt;dose titration schedule on initiating Acme Product treatment and by taking Acme Product with food (see sections 4.2 and 4.8).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p class=\"Default\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Renal function&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Since renal elimination plays a minor role in the clearance of Acme Product from plasma, it is unlikely that renal impairment would affect the pharmacokinetic characteristics, and so a need for dose adjustment in patients with mild to moderate renal impairment is not expected (see sections 4.2 and 5.2).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;During the Phase III placebo-controlled clinical trial, renal function was not seen to deteriorate during therapy across treatment groups. However, Acme Product has not been studied in patients with severe renal impairment, and some cases of renal toxicity have been reported during post-marketing surveillance with fumaric acid esters. Hence, Acme Product is contraindicated in patients with severe renal impairment (see section 4.3).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Renal function (e.g. creatinine, blood urea nitrogen and urinalysis) should be checked prior to initiation of treatment and every 3 months thereafter. In the event of a clinically relevant change in renal function, particularly in the absence of alternative explanations, consideration should be given to dosage reduction or treatment discontinuation.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Fanconi syndrome&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Early diagnosis of Fanconi syndrome and discontinuation of Acme Product treatment are important to prevent the onset of renal impairment and osteomalacia, as the syndrome is usually reversible. The most important signs are: proteinuria, glucosuria (with normal blood sugar levels), hyperaminoaciduria and phosphaturia (possibly concurrent with hypophosphatemia). Progression might involve symptoms such as polyuria, polydipsia and proximal muscle weakness. In rare cases hypophosphataemic osteomalacia with non-localised bone pain, elevated alkaline phosphatase in serum and stress fractures may occur. Importantly, Fanconi syndrome can occur without elevated creatinine levels or low glomerular filtration rate. In case of unclear symptoms Fanconi syndrome should be considered and appropriate examinations should be performed.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Hepatic function&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product has not been studied in patients with severe hepatic impairment and is contraindicated in these patients (see section 4.3). &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;It is recommended to monitor hepatic function (SGOT, SGPT, gamma‑GT, AP) prior to initiation of treatment and every 3 months thereafter, since elevation of hepatic enzymes has been observed in some patients in the Phase III study. In the event of a clinically relevant change in hepatic parameters, particularly in the absence of alternative explanations, consideration should be given to dose reduction or treatment discontinuation.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Flushing&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Patients should be made aware that they are likely to experience flushing in the first few weeks of taking Acme Product (see section 4.8).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Lactose&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "82ef2852-a680-4c3b-9076-f08c351005a9" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.5     Interaction with other medicinal products and other forms of interaction" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "20" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.5 Interaction with other medicinal products and other forms of interaction" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No interaction studies have been performed.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product should &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;be used cautiously in combination &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;with other&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;systemic antipsoriatic therapy (e.g. methotrexate, retinoids, psoralens, ciclosporin, immunosuppressants or cytostatics) (see section 4.4). &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;During treatment with Acme Product, simultaneous use of other fumaric acid derivatives (topical or systemic) should be avoided.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Concurrent therapy with nephrotoxic substances (e.g. methotrexate, ciclosporin, aminoglycosides, diuretics, NSAIDs or lithium) may increase the potential for renal adverse reactions (e.g. proteinuria) in patients taking Acme Product.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;In cases of severe or prolonged diarrhoea during treatment with Acme Product, absorption of other medicinal products may be affected. Caution should be exercised when prescribing medicinal products with a narrow therapeutic index that require absorption in the intestinal tract.&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;The efficacy of oral contraceptives may be reduced and the use of an alternative barrier contraceptive method is recommended to prevent possible failure of contraception (see the prescribing information of the oral contraceptive).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Consumption of large quantities of strong alcoholic drinks (more than 30% alcohol by volume) should be avoided because it may lead to increased dissolution rates of Acme Product and, therefore, may increase the frequency of gastrointestinal adverse reactions.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Vaccination during treatment with Acme Product has not been studied. Immunosuppression is a risk factor for the use of live vaccines. The risk of vaccination should be weighed against the benefit.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;There is no evidence for Acme Product interaction with cytochrome P450 and the most common efflux and uptake transporters, thus no interactions are expected with medicinal products metabolised or transported by these systems (see section 5.2).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 5;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "eb10e9ba-bf7d-43f3-bce8-14d2bdf5d325" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.6     Fertility, pregnancy and lactation" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "22" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.6 Fertility, pregnancy and lactation" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"Textocomentario\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span style=\"font-size:11.0pt\" lang=\"X-NONE\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"Textocomentario\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span style=\"font-size:11.0pt\" lang=\"X-NONE\"&gt;Women of child-bearing potential&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"Textocomentario\"&gt;\n                                        &lt;span style=\"font-size:11.0pt\" lang=\"X-NONE\"&gt;Acme Product is not recommended in women of child-bearing potential not using appropriate contraception. In patients experiencing diarrhoea during Acme Product treatment, the effect of oral contraceptives may be reduced and additional barrier methods of contraception may be necessary (see section 4.5).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"Textocomentario\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span style=\"font-size:11.0pt\" lang=\"X-NONE\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                &lt;/div&gt;"         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "2d5a87fc-ba92-4fe3-962e-4c6dd1067255" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Pregnancy" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "23" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Pregnancy" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;There are limited&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;data from the use of dimethyl fumarate in pregnant women. Animal studies have shown reproductive toxicity (see section 5.3). &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product is contraindicated during pregnancy (see section 4.3).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"/&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "e5373e86-6286-4cec-869d-45cdce554587" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Breast‑feeding" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "24" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Breast-feeding" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span style=\"color:black\" lang=\"EN-GB\"&gt;It is unknown whether &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;dimethyl &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;fumarate\n                                                &lt;span style=\"color:black\"&gt;or its metabolites are excreted in human milk. A risk to newborns or infants cannot be &lt;/span&gt;excluded\n                                                &lt;span style=\"color:black\"&gt;.&lt;/span&gt;\n                                            &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Therefore, Acme Product is contraindicated during breast-feeding &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;(&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;see section 4.3).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"Textocomentario\"/&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "8c5f5d68-ad92-4b71-8790-80fc716af60d" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Fertility" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "25" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Fertility" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;There are no human or animal data on the effects of Acme Product on fertility.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 6;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "20df1935-92c7-416f-a820-4faf30d9bf78" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.7     Effects on ability to drive and use machines" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "26" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.7 Effects on ability to drive and use machines" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No studies on the ability to drive and use machines have been conducted. Acme Product may have a minor influence on the ability to drive and use machines. Dizziness and fatigue may occur following administration of Acme Product (see section 4.8).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 7;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "1e27f2ed-048a-4f89-9b59-dddd00145fa2" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.8     Undesirable effects" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "27" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.8 Undesirable effects" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Summary of the safety profile&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;The most common adverse reactions observed with Acme Product in the Phase III clinical study (1102) in psoriasis patients were gastrointestinal events (62.7%), flushing (20.8%) and lymphopenia (10.0%). Most adverse reactions were considered mild and did not lead to discontinuation of study treatment. The only adverse reactions that led to discontinuation of treatment in &amp;gt;5% of patients were gastrointestinal reactions. For monitoring recommendations and clinical management of adverse reactions, see section 4.4.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Tabulated list of adverse reactions&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;The following is a list of adverse reactions experienced by patients treated with Acme Product during the clinical study and with Fumaderm, a related &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;medicinal product containing dimethyl fumarate along with other fumaric acid esters&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;The frequency of adverse reactions is defined using the following convention: very common (≥1/10); common (≥1/100 to &amp;lt;1/10); uncommon (≥1/1,000 to &amp;lt;1/100); rare (≥1/10,000 to &amp;lt;1/1,000); very rare (&amp;lt;1/10,000); and not known (cannot be estimated from available data).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-collapse:   collapse;border:none\" class=\"Tablanormal\"&gt;\n                                        &lt;thead&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;     padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;System    organ class&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"291\" style=\"width:218.6pt;border:solid windowtext 1.0pt;     border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Adverse reactions&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"121\" style=\"width:90.4pt;border:solid windowtext 1.0pt;     border-left:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span lang=\"EN-GB\"&gt;Frequency&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                        &lt;/thead&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Infections and   infestations&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Herpes zoster&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Not known**&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Blood and   lymphatic system disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Lymphopenia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Leukopenia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Eosinophilia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Leukocytosis&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Acute   lymphatic leukaemia*&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Irreversible   pancytopenia*&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very rare&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very rare&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Metabolism and   nutrition disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Decreased   appetite&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Nervous system   disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Headache&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Paraesthesia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Dizziness*&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Progressive   multifocal leukoencephalopathy&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Uncommon&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Not known&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Vascular   disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Flushing&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Gastrointestinal   disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Diarrhoea&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Abdominal   distension&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Abdominal pain&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Nausea&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Vomiting&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"IT\"&gt;Dyspepsia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Constipation&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Abdominal   discomfort&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Flatulence&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Very common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Skin and   subcutaneous tissue disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Erythema&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Skin burning   sensation&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Pruritus&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Allergic skin   reaction&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Rare&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Renal and   urinary disorders&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Proteinuria&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Renal failure&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Fanconi   syndrome&lt;/span&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;*&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Uncommon&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Not known&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Not known&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;General   disorders and administration site conditions &lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Fatigue&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Feeling hot&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Asthenia&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td width=\"207\" style=\"width:155.35pt;border:solid windowtext 1.0pt;    border-top:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Investigations&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"291\" style=\"width:218.6pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Hepatic   enzymes increased&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Serum   creatinine increased&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                            &lt;td width=\"121\" style=\"width:90.4pt;border-top:none;border-left:    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Common&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span lang=\"EN-GB\"&gt;Uncommon&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                        &lt;tr&gt;\n                                            &lt;td colspan=\"3\" width=\"619\" style=\"width:464.35pt;border:none;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span style=\"font-size:9.0pt\" lang=\"EN-GB\"&gt;*Additional adverse reactions reported with Fumaderm,   a related medicinal product containing dimethyl fumarate along with other   fumaric acid esters.&lt;/span&gt;\n                                                &lt;/p&gt;\n                                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                    &lt;span style=\"font-size:9.0pt\" lang=\"EN-GB\"&gt;**Adverse reactions reported during post marketing   experience.&lt;/span&gt;\n                                                &lt;/p&gt;\n                                            &lt;/td&gt;\n                                        &lt;/tr&gt;\n                                    &lt;/table&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Description of selected adverse reactions&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Gastrointestinal disturbances&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Data from the Phase III clinical study as well as from the literature show that gastrointestinal disorders with dimethyl fumarate‑containing products are most likely to occur during the first 2 to 3 months after starting treatment. No apparent dose relationship and no risk factors for the occurrence of these adverse reactions could be identified. Diarrhoea was a common adverse reaction (36.9%) among patients taking Acme Product, leading to medicinal product withdrawal in about 10% of patients. More than 90% of these diarrhoea events were of mild to moderate severity (see section 4.4).&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;text-autospace:none\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Flushing&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Based on observations in the Phase III clinical study as well as on literature data, flushing is most likely to occur during the early weeks of treatment and tends to lessen with time. In the clinical study a total of 20.8% of patients receiving Acme Product &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;experienced flushing, which was mild in the majority of cases (see section 4.4). Published clinical experience with dimethyl fumarate-containing products shows that individual episodes of flushing usually begin shortly after taking the tablets and resolve within a few hours.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Haematological changes&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Data from the Phase III clinical study as well as from the\nliterature show that changes in haematological parameters are most likely to\noccur during the first 3 months after starting treatment with dimethyl\nfumarate. In particular, in the clinical study there was a slight decrease in\nmean lymphocyte counts starting between weeks 3 and 5 and reaching a\nmaximum in week 12 where approximately one third of patients had\nlymphocyte values below 1.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L. The mean and median values of\nlymphocytes remained within the normal range during the clinical study. At week 16\n(end of treatment), there was no further decline in lymphocyte counts. At week\n16\n                                        &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;of treatment&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;, 13/175 (7.4%) &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;of patients were noted to have lymphocyte levels &amp;lt;0.7x 10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L.\nBlood sampling for safety clinical laboratory tests at follow-up visits was\nonly performed in case of abnormalities at the preceeding visit. During the\ntreatment free follow up, lymphocyte levels of &amp;lt;0.7x 10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L were\nobserved in 1/29 (3.5%) patient at 6 months and 0/28 (0%) at 12 months after\nstopping treatment.\n                                        &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;At 12 months after stopping treatment\n3/28 (10.7%) of patients had lymphocyte values below 1.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L,\nwhich would represent 3/279 (1.1%) of the patients started on Acme Product.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;For the total\nleukocyte count, a decline became apparent at week 12 of treatment; it\nslowly increased again at week 16 (end of treatment); and 12 months\nafter stopping treatment all patients had values above 3.0x10\n                                            &lt;sup&gt;9&lt;/sup&gt;/L.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;A transient increase in mean values of eosinophils was noted as early as week 3, reached a maximum at week 5 and 8, and had returned to baseline values at week 16. &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;For monitoring recommendations and clinical management of haematological adverse reactions, see section 4.4.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "c0d1136e-e986-4ce9-a747-16f227e8a02f" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Reporting of suspected adverse reactions" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "29" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Reporting of suspected adverse reactions" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Reporting suspected adverse reactions after &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;authorisation&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;of the medicinal product is important. It allows continued\nmonitoring of the benefit/risk balance of the medicinal product. Healthcare\nprofessionals are asked to report any suspected adverse reactions via \n                                                &lt;span style=\"background:lightgrey\"&gt;the national reporting system listed in &lt;/span&gt;\n                                            &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;\n                                                &lt;a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"&gt;\n                                                    &lt;span class=\"Hipervnculo\"&gt;\n                                                        &lt;span style=\"background:lightgrey\"&gt;Appendix V&lt;/span&gt;\n                                                    &lt;/span&gt;\n                                                &lt;/a&gt;\n                                            &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 8;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "627d26c9-ebe7-4518-a6b7-e7264a1d0f6a" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.9     Overdose" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "30" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "4.9 Overdose" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Symptomatic treatment is indicated in the case of an overdose. No specific antidote is known.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "cb0ae994-0435-4812-9a5c-ff150014510a" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.       PHARMACOLOGICAL PROPERTIES" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "32" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5. PHARMACOLOGICAL PROPERTIES" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "a91b5286-b5f8-442d-8579-cf5477337aa2" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.1     Pharmacodynamic properties" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "33" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.1 Pharmacodynamic properties" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Pharmacotherapeutic group: &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Other immunosuppressants,&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;ATC code: &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;L04AX07&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                &lt;/div&gt;"         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "98bc7dbb-bac6-440c-a5f9-a012d496b8ef" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Mechanism of action" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "34" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Mechanism of action" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The anti-inflammatory and immunomodulating effects of dimethyl fumarate and its metabolite monomethyl fumarate are not fully elucidated but are thought to be mainly due to the interaction with the intracellular reduced glutathione of cells directly involved in the pathogenesis of psoriasis. This interaction with glutathione leads to the inhibition of translocation into the nucleus and the transcriptional activity of the nuclear factor kappa‑light‑chain‑enhancer of activated B‑cells (NF‑κB).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The main activity of dimethyl fumarate and monomethyl fumarate is considered to be immunomodulatory, resulting in a shift in T helper cells (Th) from the Th1 and Th17 profile to a Th2 phenotype. The inflammatory cytokine production is reduced with induction of proapoptotic events, inhibition of keratinocyte proliferation, reduced expression of adhesion molecules, and diminished inflammatory infiltrate within psoriatic plaques.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"/&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "287a0ff0-769c-4b91-90b3-83db1a79dd2d" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Clinical efficacy and safety" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "36" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Clinical efficacy and safety" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The safety and efficacy of Acme Product was assessed in one double‑blind, &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;3‑arm, placebo‑ and active comparator-controlled Phase III study (1102) in patients with moderate to severe plaque psoriasis (Study 1102). 704 patients were randomised to receive Acme Product, an active comparator (Fumaderm, a combination product with the same content of &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;dimethyl fumarate plus&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;3 monoethyl fumarate salts) and placebo in a ratio of 2:2:1. Patients began treatment with tablets containing 30 mg/day &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;dimethyl fumarate&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;or placebo, titrating up to a maximum of 720 mg/day in both active treatment arms as described in section 4.2. &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;If treatment success was observed before the maximum dose of 720 mg/day of dimethyl fumarate was reached, no further increase of dosage was necessary and the dosage was to be steadily reduced to an individual maintenance dose. In case of individual intolerability of the increased dosage during weeks 4 to 16, the patient was to return to the last tolerated dose taken since the start of week 4, which was to be maintained until end of the treatment period (week 16). &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Patients received treatment for up to 16 weeks and follow-up visits were planned for up to 12 months after treatment was stopped.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The demographic and baseline characteristics were well balanced between the treatment &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;groups&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;. Of the 699 patients, most were Caucasian (99%) and male (65%), and the mean age was 44 years. Most patients (91%) were &amp;lt;65 years of age. Most patients had moderate psoriasis based on Psoriasis Area and Severity Index (PASI) and Physician’s Global Assessment (PGA) scores at baseline: the mean PASI score at baseline was 16.35 and 60% of patients scored as moderate on the PGA. The majority of patients reported a “very large” or “extremely large” effect of psoriasis on their life based on the Dermatology Life Quality Index (DLQI), with a mean DLQI score of 11.5.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal;text-autospace:none\" class=\"MsoNormal\"&gt;\n                                            &lt;a name=\"_Ref431313822\"&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;After 16 weeks of treatment, Acme Product was found to be superior to placebo (p&amp;lt;0.0001) based on PASI 75 and PGA score clear or almost clear and non‑inferior (using a non-inferiority margin of ‑15%) to the active comparator (p&amp;lt;0.0003) based on PASI 75. &lt;/span&gt;\n                                            &lt;/a&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                        &lt;table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"612\" style=\"border-collapse:collapse\" class=\"Tablanormal\"&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"7\" width=\"612\" style=\"width:459.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;Summary of clinical efficacy after   16 weeks treatment in Study 1102&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;border:none;border-top:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Assessment&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"123\" style=\"width:92.15pt;border:none;    border-top:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Acme Product&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"95\" style=\"width:70.9pt;border:none;border-top:    solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Placebo&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"123\" style=\"width:92.1pt;border:none;border-top:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Fumaderm&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;border:none;border-bottom:    solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"123\" style=\"width:92.15pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;N=267&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"95\" style=\"width:70.9pt;border:none;border-bottom:    solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;N=131&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"123\" style=\"width:92.1pt;border:none;border-bottom:solid windowtext 1.0pt;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;N=273&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"7\" width=\"612\" style=\"width:459.0pt;border:none;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Superiority testing vs placebo&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:justify;text-justify:inter-ideograph;    line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;PASI 75&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;, n (%)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"123\" style=\"width:92.15pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;100 (37.5)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"95\" style=\"width:70.9pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;20 (15.3)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"123\" style=\"width:92.1pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;110 (40.3)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;p-value&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.6pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-right:15.85pt;text-align:right;    line-height:normal;page-break-after:avoid\" align=\"right\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;&amp;lt;0.0001\n                                                            &lt;sup&gt;a&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.55pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:15.85pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;&amp;lt;0.0001\n                                                            &lt;sup&gt;a&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Two-sided 99.24% CI&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.6pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-right:14.2pt;text-align:right;    line-height:normal;page-break-after:avoid\" align=\"right\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;10.7, 33.7&lt;/span&gt;\n                                                        &lt;sup&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;a&lt;/span&gt;\n                                                        &lt;/sup&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.55pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:8.75pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;13.5, 36.6&lt;/span&gt;\n                                                        &lt;sup&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;a&lt;/span&gt;\n                                                        &lt;/sup&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;PGA score clear or almost clear,&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;n (%)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"123\" style=\"width:92.15pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;88 (33.0)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"95\" style=\"width:70.9pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;17 (13.0)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td width=\"123\" style=\"width:92.1pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;102 (37.4)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;p-value&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.6pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-right:15.85pt;text-align:right;    line-height:normal;page-break-after:avoid\" align=\"right\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;&amp;lt;0.0001\n                                                            &lt;sup&gt;a&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.55pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:15.85pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;&amp;lt;0.0001\n                                                            &lt;sup&gt;a&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td width=\"272\" style=\"width:203.85pt;border:none;border-bottom:    solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Two-sided 99.24% CI&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.6pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-right:14.2pt;text-align:right;    line-height:normal;page-break-after:avoid\" align=\"right\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;9.0, 31.0&lt;/span&gt;\n                                                        &lt;sup&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;a&lt;/span&gt;\n                                                        &lt;/sup&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"170\" style=\"width:127.55pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:8.75pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;13.3, 35.5&lt;/span&gt;\n                                                        &lt;sup&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;a&lt;/span&gt;\n                                                        &lt;/sup&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"142\" style=\"width:106.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Acme Product&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"151\" style=\"width:113.4pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;Fumaderm&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"142\" style=\"width:106.3pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;N=267&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"151\" style=\"width:113.4pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;N=273&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;border:none;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:justify;text-justify:inter-ideograph;    line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;Non-inferiority of Acme Product vs. Fumaderm&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"142\" style=\"width:106.3pt;border:none;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"151\" style=\"width:113.4pt;border:none;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"/&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:justify;text-justify:inter-ideograph;    line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;PASI 75&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                        &lt;span style=\"font-size:    10.0pt\" lang=\"NL-BE\"&gt;, n (%)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"142\" style=\"width:106.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;100 (37.5)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"151\" style=\"width:113.4pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;110 (40.3)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;p-value&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"5\" width=\"293\" style=\"width:219.7pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;0.0003\n                                                            &lt;sup&gt;b&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;One-sided 97.5% repeated CI   (lower limit)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"5\" width=\"293\" style=\"width:219.7pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;-11.6\n                                                            &lt;sup&gt;b&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;b&gt;\n                                                            &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;PGA score clear or almost clear,&lt;/span&gt;\n                                                        &lt;/b&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;n (%)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"3\" width=\"142\" style=\"width:106.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;88 (33.0)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"2\" width=\"151\" style=\"width:113.4pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;102 (37.4)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;p-value&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"5\" width=\"293\" style=\"width:219.7pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;0.0007\n                                                            &lt;sup&gt;b&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"2\" width=\"319\" style=\"width:239.3pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"margin-left:7.1pt;line-height:normal;page-break-after:    avoid\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"EN-GB\"&gt;One-sided 97.5% repeated CI   (lower limit)&lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                                &lt;td colspan=\"5\" width=\"293\" style=\"width:219.7pt;border:none;    border-bottom:solid windowtext 1.0pt;padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"text-align:center;line-height:normal;    page-break-after:avoid\" align=\"center\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:10.0pt\" lang=\"NL-BE\"&gt;-13.0\n                                                            &lt;sup&gt;b&lt;/sup&gt;\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr&gt;\n                                                &lt;td colspan=\"7\" width=\"612\" style=\"width:459.0pt;border:none;    padding:1.4pt 5.4pt 1.4pt 5.4pt\" valign=\"top\"&gt;\n                                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                                        &lt;span style=\"font-size:9.0pt\" lang=\"EN-GB\"&gt;Fumaderm = Active comparator, a combination product\nwith the same content of dimethyl fumarate plus 3 monoethyl hydrogen fumarate\nsalts; n=number of patients with available data; N=number of patients in population;\nPASI=Psoriasis Area Severity Index; PGA=Physician’s Global Assessment; \n                                                            &lt;sup&gt;a&lt;/sup&gt;\nSuperiority of Acme Product vs. Placebo with a difference of 22.2% for PASI 75\nand 20.0% for PGA score clear or almost clear, superiority of Fumaderm vs\nPlacebo with a difference of 25.0% for PASI 75 and 24.4% for PGA score clear\nor almost clear;\n                                                            &lt;sup&gt;b&lt;/sup&gt;Non-inferiority of Acme Product vs. Fumaderm with\na difference of -2.8% for PASI 75 and -4.4% for PGA score clear or almost\nclear.\n                                                        &lt;/span&gt;\n                                                    &lt;/p&gt;\n                                                &lt;/td&gt;\n                                            &lt;/tr&gt;\n                                            &lt;tr height=\"0\"&gt;\n                                                &lt;td width=\"272\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"47\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"76\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"47\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"19\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"28\" style=\"border:none\"/&gt;\n                                                &lt;td width=\"123\" style=\"border:none\"/&gt;\n                                            &lt;/tr&gt;\n                                        &lt;/table&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;There was a trend in the efficacy endpoint PASI score mean % change from baseline, indicating the onset of a clinical response to Acme Product as early as week 3 (‑11.8%) which became statistically significant compared to placebo by week 8 (‑30.9%). Further improvement was seen by week 16 (‑50.8%).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The benefits of treatment with Acme Product were also supported by patient self-perceived improvements in their quality of life. At week 16, patients treated with Acme Product had a lower mean &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;DLQI &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;compared to placebo (5.4 vs 8.8). &lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Rebound (defined as worsening of ≥125% of baseline PASI value) was assessed after 2 months off treatment and was shown not to be a clinical concern with fumaric acid esters, as it was documented in very few patients (Acme Product 1.1% and active comparator 2.2%, compared to 9.3% in the placebo group). &lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Long-term efficacy data are currently not available for Acme Product, however, in the pharmacokinetic and clinical studies the systemic exposure, efficacy and safety of Acme Product were shown to be comparable to the active comparator containing dimethyl fumarate. Hence it is reasonable to expect the long-term efficacy of Acme Product to also be comparable to dimethyl fumarate-containing products. Maintenance of long term efficacy has been well described for other dimethyl fumarate-containing products, and therefore&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;the treatment benefits seen with Acme Product at 16 weeks can be expected to be maintained in patients treated over the long term for at least 24 months.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "5ab2635e-33fb-43f8-a230-331d9af876af" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Paediatric population" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "37" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Paediatric population" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The European Medicines Agency has waived the obligation to submit the results of studies with Acme Product in all subsets of the paediatric population in this indication (see section 4.2 for information on paediatric use).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "720b477a-8a7b-40aa-af90-a3f7e50d859b" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.2     Pharmacokinetic properties" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "38" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.2 Pharmacokinetic properties" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"/&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                &lt;/div&gt;"         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "da20d2ae-98f5-496e-94bc-1802b8385182" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Absorption" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "39" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Absorption" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;After oral administration, dimethyl fumarate is not detected in plasma because it is rapidly hydrolysed by esterases to its active metabolite monomethyl fumarate. After oral administration of a single Acme Product 120 mg tablet in healthy subjects, &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;monomethyl fumarate&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;reached plasma peak concentrations of around 1325 ng/mL and 1311 ng/mL\nunder fasted or fed conditions, respectively. Taking Acme Product with food delayed\nthe t\n                                                &lt;sub&gt;max&lt;/sub&gt;of\n                                            &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;monomethyl fumarate&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;from 3.5 to 9.0 hours.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "e8921b14-906e-43ac-9b4a-9dc29bc75193" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Distribution" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "40" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Distribution" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The plasma protein binding of &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;monomethyl fumarate&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;is around 50%. Dimethyl fumarate does not show any binding affinity to serum proteins which may further contribute to its rapid elimination from the circulation.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "9023e2fa-7fef-4797-a49d-cbe33662b539" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Biotransformation" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "41" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Biotransformation" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The biotransformation of dimethyl fumarate does not involve cytochrome P450 isoenzymes.&lt;/span&gt;\n                                            &lt;i&gt;In vitro &lt;/i&gt;studies have shown that monomethyl fumarate at the therapeutic dose\ndoes not inhibit or induce any of the cytochrome P450 enzymes, it is not a\nsubstrate or inhibitor of P‑glycoprotein and is not an inhibitor of the\nmost common efflux and uptake transporters\n                                            &lt;span style=\"color:#4BA524;  background:white\"&gt;. &lt;/span&gt;\n                                            &lt;span style=\"color:black;background:white\"&gt;In vitro studies have shown that dimethyl fumarate at a therapeutic dose does not inhibit CYP3A4/5 and BCRP and is a weak P-glycoprotein inhibitor.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" id=\"8a56455c-0939-4203-b538-47f084199bc9\" class=\"MsoNormal\"/&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;In vitro&lt;/span&gt;\n                                        &lt;/i&gt;\n                                        &lt;none/&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" id=\"8a56455c-0939-4203-b538-47f084199bc9\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;studies have shown that hydrolysis of dimethyl fumarate to &lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;monomethyl fumarate&lt;/span&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;occurs rapidly at pH&nbsp;8 (pH in the small intestine), but not at pH&nbsp;1 (pH in the stomach). A part of the total dimethyl fumarate is hydrolysed by esterases and the alkaline milieu of the small intestine, while the remainder enters the portal vein blood. Further studies have shown that dimethyl fumarate (and to a lesser extent monomethyl fumarate) reacts partially with reduced glutathione forming a glutathione-adduct. These adducts were detected in animal studies in the intestinal mucosa of rats and to a smaller extent in portal vein blood. Unconjugated dimethyl fumarate, however, cannot be detected in the plasma of animals or psoriatic patients following oral administration. By contrast, unconjugated monomethyl fumarate is detectable in plasma. Further metabolism occurs through oxidation via the tricarboxylic acid cycle forming carbon dioxide and water.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"/&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "eb9c8a8f-0479-46a7-a0bd-ef051ba2f140" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Elimination" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "42" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Elimination" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Exhalation of CO\n                                                &lt;sub&gt;2&lt;/sub&gt;resulting from the metabolism of monomethyl\nfumarate is the primary route of elimination; only small amounts of intact monomethyl\nfumarate are excreted through urine or faeces. The portion of dimethyl fumarate\nthat reacts with glutathione, forming a glutathione-adduct, is metabolised further\nto its mercapturic acid, which is excreted in the urine.\n                                            &lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;The apparent terminal elimination half-life of monomethyl fumarate is about 2 hours.&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"/&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                    &lt;/div&gt;"           ]         ], [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "8d925827-abee-49bc-a037-513c0e9fe36d" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Linearity/non-linearity" ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
               <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "43" ];
               <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "Linearity/non-linearity" ]             ]           ];
           <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
             <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
             fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Despite the high inter‑subject variability, the exposure\nmeasured as AUC and C\n                                                &lt;sub&gt;max&lt;/sub&gt;was generally dose‑proportional after\nsingle dose administration of 4 x 30 mg dimethyl fumarate\ntablets (total dose of 120 mg) and 2 x 120 mg dimethyl\nfumarate tablets (total dose of 240 mg).\n                                            &lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"/&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;No specific studies have been performed in patients with renal impairment. However, because renal elimination plays a minor role in the total clearance from plasma, it is unlikely that renal impairment may affect the pharmacokinetic characteristics of Acme Product (see section 4.2).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;u&gt;\n                                                &lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;\n                                            &lt;/u&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;No specific studies have been performed in patients with hepatic impairment. However, as dimethyl fumarate is metabolised by esterases and the alkaline milieu of the small intestine without the involvement of cytochrome P450, hepatic impairment is not expected to influence exposure (see section 4.2).&lt;/span&gt;\n                                        &lt;/p&gt;\n                                        &lt;p style=\"margin-right:-.1pt;line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;/div&gt;"           ]         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "1f440f74-bf3d-4bb2-8c68-71ab0ef0f1b1" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.3     Preclinical safety data" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "45" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "5.3 Preclinical safety data" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Non-clinical safety pharmacology and genotoxicity data reveal no special hazard for humans.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Toxicology&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;The kidney was identified as a major target organ of toxicity in\nnon-clinical studies. Renal findings in dogs included minimal to moderate\ntubular hypertrophy, increased incidence and severity of tubular vacuolation\nand minimal to slight tubular degeneration, which were considered\ntoxicologically relevant. The no‑observed adverse-effect-level (NOAEL) after\n3 months of treatment was 30 mg/kg/day, which corresponds to 2.9‑fold\nand 9.5‑fold the human systemic exposure at the highest recommended dose\n(720 mg/day), as AUC and C\n                                            &lt;sub&gt;max&lt;/sub&gt;values, respectively.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Reproduction toxicity&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No fertility or pre- and post-natal development studies have been conducted with Acme Product.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;There were no effects on foetal body weights or malformations attributed to maternal administration of dimethyl fumarate&lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;during the embryo‑foetal development study in rats. However, there\nwas an increased number of foetuses with the variations “supernumerary liver\nlobe” and “abnormal iliac alignment” at maternally toxic doses. The NOAEL for\nmaternal and embryo‑foetal toxicity was 40 mg/kg/day, corresponding\nto 0.2‑fold and 2.0‑fold the human systemic exposure at the highest\nrecommended dose (720 mg/day), as AUC and C\n                                            &lt;sub&gt;max&lt;/sub&gt;values, respectively.\n                                        &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Dimethyl fumarate has been shown to cross the placental membrane into foetal blood in rats.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Carcinogenicity&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No carcinogenicity studies have been performed for &lt;/span&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Acme Product. Based on available data suggesting that fumaric acid esters may activate cellular pathways related to the development of renal tumours, a potential tumorigenic activity of exogenously administered dimethyl fumarate on the kidneys cannot be excluded. &lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 5;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "19c20d39-2aec-47da-bd18-652906b34674" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.       PHARMACEUTICAL PARTICULARS" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "47" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6. PHARMACEUTICAL PARTICULARS" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.section">fhir:Composition.section.section</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "e42a068f-0638-4e16-8922-63a0f7f57950" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.1     List of excipients" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "48" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.1 List of excipients" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;and Acme Product 120 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Core:&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Lactose monohydrate&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Cellulose microcrystalline&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Croscarmellose sodium&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Colloidal anhydrous silica&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Magnesium stearate&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Coating:&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Methacrylic acid-ethyl acrylate copolymer (1:1)&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Talc&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Triethyl citrate&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Titanium dioxide (E171)&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Simethicone&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"IT\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;i&gt;\n                                            &lt;span lang=\"IT\"&gt;Coating:&lt;/span&gt;\n                                        &lt;/i&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Methacrylic acid‑ethyl acrylate copolymer (1:1)&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Talc&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Triethyl citrate&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Titanium dioxide (E171)&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Simethicone&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Indigo carmine (E132)&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"IT\"&gt;Sodium hydroxide&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "dee6ec5e-c60c-4d3d-9102-028d52f66401" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.2     Incompatibilities" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "49" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.2 Incompatibilities" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Not applicable.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "ed475b82-681f-451a-975d-f5dff771bb6e" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.3     Shelf life" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "50" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.3 Shelf life" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;3 years.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "6f70519b-7d31-4a8b-a8c0-b0cac0305010" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.4     Special precautions for storage" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "51" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.4 Special precautions for storage" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;This medicinal product does not require any special storage conditions.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "2ef2c4b5-814c-4b7a-9caa-f3e162cc3721" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.5     Nature and contents of container" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "52" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.5 Nature and contents of container &lt;and special equipment for use administration or implantation&gt;" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 30 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;42, 70 and 210 gastro‑resistant tablets in PVC/PVDC‑aluminium blister packs.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;u&gt;\n                                            &lt;span lang=\"EN-GB\"&gt;Acme Product 120 mg&lt;/span&gt;\n                                        &lt;/u&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;40, 70, 90, 100, 120, 180, 200, 240, 300, 360 and 400 gastro‑resistant tablets in PVC/PVDC‑aluminium blister packs.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;Not all pack sizes may be marketed.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 5;
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "21dbeb54-74c6-459c-b1c2-45de7b3f7fc5" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.6     Special precautions for disposal" ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
             <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "53" ];
             <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "6.6 Special precautions for disposal &lt;and other handling&gt;" ]           ]         ];
         <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
           <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
           fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                        &lt;span lang=\"EN-GB\"&gt;No special requirements for disposal.&lt;/span&gt;\n                                    &lt;/p&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                    &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;/div&gt;"         ]       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 6;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "d5d42c5e-8403-4a80-a88b-80cecd512160" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "7.       MARKETING AUTHORISATION HOLDER" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "55" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "7. MARKETING AUTHORISATION HOLDER" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Almirall, S.A.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Ronda General Mitre, 151&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;08022 Barcelona&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Spain&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 7;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "d6ced554-6fec-456f-9486-3f9734a0cfb0" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "8.       MARKETING AUTHORISATION NUMBERS" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "56" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "8. MARKETING AUTHORISATION NUMBER(S)" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"PT\"&gt;EU/1/17/1201/001\n                                        &lt;br/&gt;\nEU/1/17/1201/002\n                                        &lt;br/&gt;\nEU/1/17/1201/003\n                                        &lt;br/&gt;\nEU/1/17/1201/004\n                                        &lt;br/&gt;\nEU/1/17/1201/005\n                                        &lt;br/&gt;\nEU/1/17/1201/006\n                                        &lt;br/&gt;\n                                    &lt;/span&gt;\n                                    &lt;span lang=\"PT\"&gt;EU/1/17/1201/007\n                                        &lt;br/&gt;\n                                    &lt;/span&gt;\n                                    &lt;span lang=\"PT\"&gt;EU/1/17/1201/008\n                                        &lt;br/&gt;\nEU/1/17/1201/009\n                                        &lt;br/&gt;\n                                    &lt;/span&gt;\n                                    &lt;span lang=\"PT\"&gt;EU/1/17/1201/010\n                                        &lt;br/&gt;\nEU/1/17/1201/011\n                                    &lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;EU/1/17/1201/012&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;EU/1/17/1201/013&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;EU/1/17/1201/014&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 8;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "911c0af5-bcba-4be7-824f-98340e25012d" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "57" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Date of first authorisation: 23 june 2017&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal\" class=\"MsoNormal\"/&gt;\n                            &lt;/div&gt;"       ]     ], [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 9;
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.id">fhir:Element.id</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#id">fhir:value</a> "cfe505d7-6992-4128-a84d-606d2a8f0680" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.title">fhir:Composition.section.title</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "10.     DATE OF REVISION OF THE TEXT" ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.code">fhir:Composition.section.code</a> [
         <a href="http://build.fhir.org/branches/R4B//datatypes.html#CodeableConcept#CodeableConcept.coding">fhir:CodeableConcept.coding</a> [
           <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.system">fhir:Coding.system</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#uri">fhir:value</a> "http://spor.ema.europa.eu/v1/example-sections" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.code">fhir:Coding.code</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "58" ];
           <a href="http://build.fhir.org/branches/R4B//datatypes.html#Coding#Coding.display">fhir:Coding.display</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#string">fhir:value</a> "10. DATE OF REVISION OF THE TEXT" ]         ]       ];
       <a href="http://build.fhir.org/branches/R4B//composition.html#Composition.section.text">fhir:Composition.section.text</a> [
         <a href="http://build.fhir.org/branches/R4B//narrative.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/branches/R4B//datatypes.html#code">fhir:value</a> "additional" ];
         fhir:Narrative.div "&lt;div xmlns=\"http://www.w3.org/1999/xhtml\"&gt;\n                                &lt;p style=\"margin-right:-.1pt;line-height:normal;page-break-after:  avoid\" class=\"MsoNormal\"/&gt;\n                                &lt;p style=\"line-height:normal;page-break-after:avoid\" class=\"MsoNormal\"&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Detailed information on this medicinal product is available on the website of the European &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Medicines&lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;Agency &lt;/span&gt;\n                                    &lt;span lang=\"EN-GB\"&gt;\n                                        &lt;a href=\"http://www.ema.europa.eu\"&gt;\n                                            &lt;span class=\"Hipervnculo\"&gt;http://www.ema.europa.eu&lt;/span&gt;\n                                        &lt;/a&gt;\n                                    &lt;/span&gt;\n                                    &lt;span style=\"color:blue\" lang=\"EN-GB\"&gt;.&lt;/span&gt;\n                                &lt;/p&gt;\n                                &lt;p style=\"margin-right:-.1pt;line-height:normal\" class=\"MsoNormal\"/&gt;\n                                &lt;span style=\"font-size:11.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,serif\" lang=\"EN-GB\"&gt;\n                                    &lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;\n                                &lt;/span&gt;\n                            &lt;/div&gt;"       ]     ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.

</code></pre>



    <!-- insert notes if present -->
  



</div>
        </div>    <!-- /inner-wrapper -->
      </div>    <!-- /row -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-content -->

  <script src="assets/js/jquery.js" type="text/javascript"> </script>       <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script src="assets/js/jquery-ui.min.js" type="text/javascript"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div igtool="footer" id="segment-footer" class="segment">    <!-- segment-footer -->
    <div class="container">    <!-- container -->

      <div class="inner-wrapper">
        <p><a name="18759360-afba-4dc1-ba0a-ab59dea69d6d">​</a>
          IG &copy; 2021+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.gravitatehealth.eu/"></a>.  Package hl7.eu.fhir.gh#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://build.fhir.org/">FHIR 4.1.0</a>. Generated <span title="Tue, Aug 17, 2021 20:14+0000">2021-08-17</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)"></span>
            <div style="color: #33333">
	Links: <a style="color: #81BEF7" href="toc.html">Table of Contents</a> |
	<a style="color: #81BEF7" href="qa.html">QA Report</a>
	  <!-- <a style="color: #81BEF7" target="_blank" href="http://hl7.eu/fhir/ig/gravitate-health/history.html">Version History <img alt="external" style="vertical-align: baseline" src="external.png"/></a></a> | -->
	<a rel="license" style="color: #81BEF7" href="http://build.fhir.org/license.html">
		<img src="cc0.png" alt="CC0" style="border-style: none;"/>
	</a>
	  <!-- <a style="color: #81BEF7" href="todo.html">Search</a> | -->
	  <!-- <a style="color: #81BEF7" target="_blank" href="mailto:mail@hl7belgium.org">Propose a change<img alt="external" style="vertical-align: baseline" src="external.png"/></a> -->
	  <!-- <br/>				 
				 <a style="color: #81BEF7" rel="eufunded" href="https://europa.eu"><img style="border-style: none;" alt="EU" src="assets/images/en_horizontal_cef_logo.png" width="250"/></a> -->
	<div id="container width=100% style=&quot;display:block;&quot; ">
		<div style="float: left; padding-top: 17px; padding-bottom: 17px;">The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.<br/>
			This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.</div>
		<div style="float: right; width: 69px; vertical-align:middle; text-align:center; padding-top: 17px; padding-bottom: 17px;">
			<img src="assets/images/eu.png" alt="a EU funded project" height="41"/>
		</div>
	</div>
	<div>
	</div>
</div>
          
        </p>
      </div>    <!-- /inner-wrapper -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">    <!-- segment-post-footer -->
    <div class="container">    <!-- container -->
    </div>    <!-- /container -->
  </div>    <!-- /segment-post-footer -->
  
    <!-- JS and analytics only. -->
    <!-- Bootstrap core JavaScript
  ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
  <script src="assets/js/bootstrap.min.js" type="text/javascript"> </script>
  <script src="assets/js/respond.min.js" type="text/javascript"> </script>
  <script src="assets/js/anchor.min.js" type="text/javascript"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
  <!-- feedback form - Google forms -->
  <!-- v0.1, 2021-01-09 -->



  <!-- / feedback form -->

    <!-- Analytics Below
  ================================================== -->
  </body>
</html>